Skip to content

study on prolongation of spinal analgesia using Inj Bupivacaine 0.5% (H) and Inj Bupivacaine 0.5% (H) with Inj Clonidine 60 µ as a single shot Intrathecal injection.

A randomized case control study on prolongation of spinal analgesia using Inj Sensorcaine 0.5% (H) and Inj Sensorcaine 0.5% (H) with Inj Clonidine 60 µ as a single shot Intrathecal injection.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/04/002556
Enrollment
100
Registered
2012-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients undergoing lower abdomen and lower limb surgeries

Interventions

Intervention1: Inj Bupivacaine 0.5 % (H)3 ml (15 mg ) + 0.4 ml Normal Saline: To be given as single shot intra-thecal injection Intervention2: Inj Bupivacaine 0.5 % (H) 3 ml (15 mg) + Inj Clonidine 60

Sponsors

Peoples Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade I & II patients undergoing lower abdomen and lower limb surgeries.

Exclusion criteria

Exclusion criteria: All the patients who have contraindications to spinal anesthesia will be excluded. Patients undergoing emergency surgeries and pregnant patients will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
motor block regession in bromage score,sensory block regession by pin prick senstion to dermatomes,time to requirement to first analgesic in post operative period,any other side effects like nausea,headache,itching etcTimepoint: 4 to 8 hours after intra thecal injection

Secondary

MeasureTime frame
sensory block regession by pin prick senstion to dermatomes,time to requirement to first analgesic in post operative period, any other side effects like nausea,headache,itching etcTimepoint: nil

Countries

India

Contacts

Public ContactDr M R Gaikwad

Peoples College of Medical Sciences and Research Center

mrgaikwad11@yahoo.com9993226907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026